BeyondSpring, Inc. (BYSI)
0.4311
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.4376
+0.01
(+1.51%)
After-Hours: 20:00
BeyondSpring Net Income (Quarterly) : -1.75M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.75M |
| March 31, 2026 | -2.351M |
| December 31, 2025 | -2.51M |
| September 30, 2025 | -1.743M |
| June 30, 2025 | -1.878M |
| March 31, 2025 | -2.584M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -10.73M |
| September 30, 2021 | -20.14M |
| June 30, 2021 | -19.89M |
| March 31, 2021 | -17.44M |
| December 31, 2020 | -18.38M |
| Date | Value |
|---|---|
| September 30, 2020 | -15.18M |
| June 30, 2020 | -13.60M |
| March 31, 2020 | -16.66M |
| December 31, 2019 | -15.06M |
| September 30, 2019 | -9.824M |
| June 30, 2019 | -7.62M |
| March 31, 2019 | -7.827M |
| December 31, 2018 | -14.71M |
| September 30, 2018 | -15.90M |
| June 30, 2018 | -12.79M |
| March 31, 2018 | -14.08M |
| December 31, 2017 | -16.29M |
| September 30, 2017 | -17.51M |
| June 30, 2017 | -14.88M |
| March 31, 2017 | -47.71M |
| December 31, 2016 | -3.691M |
| September 30, 2016 | |
| June 30, 2016 | -3.683M |
| March 31, 2016 | -1.909M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.909M |
| EPS Diluted (Quarterly) | -0.0206 |
| Enterprise Value | 10.91M |
| Earnings Yield | -38.02% |
| Normalized Earnings Yield | -38.02 |